Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma

NCT04458922 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

27

Enrollment

NIH

Sponsor class

Conditions

Central Chondrosarcoma, Grade 2
Central Chondrosarcoma, Grade 3
Dedifferentiated Chondrosarcoma
Metastatic Clear Cell Sarcoma of Soft Tissue
Metastatic Primary Central Chondrosarcoma
Unresectable Primary Central Chondrosarcoma

Interventions

DRUG: Atezolizumab
PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography

Sponsor

National Cancer Institute (NCI)